Literature DB >> 2982235

Transformation of erythroid cells by Rous sarcoma virus (RSV).

S Palmieri.   

Abstract

RSV transforms several nonhematopoietic cell types and as reported here also has the capacity to transform hematopoietic cells of the erythroid lineage. In vitro, the three RSV isolates tested induced erythroblast-like colonies in infected bone marrow cells that were distinguishable by size and cell arrangement from those induced by avian erythroblastosis virus (AEV). Also in contrast to AEV-transformed erythroblast cultures, isolated cell colonies induced by RSV required complex growth conditions in liquid medium similar to the in vitro conditions necessary for erythroblasts transformed by the acute leukemia virus E26. Temperature-shift experiments using temperature-sensitive (ts) NY68 RSV revealed that when grown at the nonpermissive temperature (42 degrees), mutant-infected cells became benzidine positive and partially differentiated into erythrocytes. Wild-type (wt) RSV-transformed cells did not undergo similar changes. However, both wt RSV-, and to a greater extent, ts RSV-transformed cultures at the permissive temperature (37 degrees) did contain populations of spontaneously differentiating erythroid cells signifying that the transforming activity of the virus did not fully arrest erythroid maturation. In addition, the RSV-transformed cells did express tyrosine kinase activity. When injected intravenously into birds, RSV induced an erythroblastosis-like disease similar to AEV but also caused fibrosarcomas and leg paralysis. These results show that RSV can alter the pattern of erythroid differentiation in a manner similar to, but distinct from, AEV and indicate that the tyrosine-specific pp60src kinase is involved in erythroid cell transformation. Since the src and erb B proteins share a significant amino acid homology, these data suggest that both may also share a common functional homology.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982235     DOI: 10.1016/0042-6822(85)90365-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Lyn kinase promotes erythroblast expansion and late-stage development.

Authors:  Vinit G Karur; Clifford A Lowell; Peter Besmer; Valter Agosti; Don M Wojchowski
Journal:  Blood       Date:  2006-05-16       Impact factor: 22.113

2.  Perturbed hemopoiesis and the generation of multipotential stem cell clones in src-infected bone marrow cultures is an indirect or transient effect of the oncogene.

Authors:  J A Wyke; A W Stoker; S Searle; E Spooncer; P Simmons; T M Dexter
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

3.  Isolation of an MH2 retrovirus mutant temperature sensitive for macrophage but not fibroblast transformation.

Authors:  S Palmieri
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

4.  Creation of a chimeric oncogene: analysis of the biochemical and biological properties of v-erbB/src fusion polypeptide.

Authors:  M L Privalsky
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

5.  Identification of three sequence-specific DNA-binding proteins which interact with the Rous sarcoma virus enhancer and upstream promoter elements.

Authors:  G H Goodwin
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

6.  A murine recombinant retrovirus containing the src oncogene transforms erythroid precursor cells in vitro.

Authors:  S M Anderson; S P Klinken; W D Hankins
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

7.  A single point mutation in erbA restores the erythroid transforming potential of a mutant avian erythroblastosis virus (AEV) defective in both erbA and erbB oncogenes.

Authors:  K Damm; H Beug; T Graf; B Vennström
Journal:  EMBO J       Date:  1987-02       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.